Two cases of mucosa associated lymphoma (pseudolymphoma) of the lung are described which highlight the varied clinical and radiological features of this rare pulmonary condition. Foliowing chemotherapy with prednisolone and chlorambucil, both patients are disease free three years later. (Thorax 1993;48:670-672) The term "pseudolymphoma" was originally introduced to describe a rare pulmonary tumour which pursued a benign course and only exceptionally disseminated. to normal. Her chest radiograph also returned to normal with the exception of an area of atelectasis in the right mid zone.
A 67 year old woman was seen with a four month history of progressive dyspnoea, a cough productive of yellow sputum, and several episodes of haemoptysis. These symptoms had failed to respond to three courses of antibiotics and she had lost one stone in weight. On the left lung were studded with firm nodules varying in size from a few millimetres to several centimetres. CT scanning of chest and abdomen showed no evidence of nodal spread or other foci of disease. Treatment with monthly pulses of prednisolone, 40 mg daily for 5 days, and chlorambucil, 4 mg daily for 14 days, was followed by resolution of symptoms and signs and she remains symptom free four years later on intermittent chlorambucil alone. Her chest radiograph now shows residual scarring only.
HISTOLOGY
The histological features were similar in both cases. The pulmonary architecture was effaced by a dense interstitial lymphoid infiltrate containing occasional germinal centres. Cytologically this was characterised by an admixture of cells, the most prominent of which was a small centrocyte like cell with an angulated or cleaved nucleus and often a small nucleolus. Small numbers of larger transformed cells with ovoid vesicular nuclei with prominent nucleoli were also present ( fig  3A) . Also noted were varying numbers of plasma cells, eosinophils, and macrophages. There was infiltration of the bronchial epithelium by centrocyte like cells forming characteristic lymphoepithelial lesions ( fig 3B) . In case 2 occasional small granulomas were seen. Immunohistochemical staining revealed the lymphoid cells to be B cells; staining for immunoglobulin light chains showed kappa light chain restriction indicating a monoclonal proliferation. These appearances were interpreted as being indicative of primary low grade lymphoma (MALT lymphoma) of the lung.5
Discussion
The term "pseudolymphoma" of the lung was adopted by Saltzstein' in 1963 to describe localised tumours of small lymphocytes, which were more indolent than those at other sites, with a long latency before spread and therefore a long survival of affected patients. In addition to small lymphocytes, these tumours characteristically contain a mixed cellular infiltrate and true germinal centres, while local lymph nodes are not involved. "Pseudolymphoma" was thought to be a chronic inflammatory process, perhaps a manifestation of autoimmunity.' 6 Several recent studies of "pseudolymphomas" and more diffuse lymphoid proliferations within the lung (including many cases of lymphocytic interstitial pneumonitis) with immunohistochemical techniques, however, have indicated monoclonality of the lymphoid population in most cases.3479 The majority are B cell in origin and the stomach is the commonest site. "Pseudolymphoma" is thus a misnomer, and such tumours and many cases of lymphocytic interstitial pneumonia should be recognised as true lymphomas of MALT, with histological features distinct from nodal lymphomas.
As MALT lymphoma is uncommon there are no clear guidelines for its management. [1] [2] Localised disease has been successfully treated by excision alone.' 5 Patients with more diffuse disease within the lungs tend to have symptoms and have a worse prognosis.5 9 Numerous different chemotherapeutic agents have been tried for patients with more diffuse disease, either alone or in combination, with varying success.'48 One 48 year old woman with a recurrent pleural effusion associated with lymphoid interstitial pneumonitis (monoclonality of lymphocytes found) responded partially to unacceptably high doses of steroids and the addition of chlorambucil permitted withdrawal of steroids. She was treated with chlorambucil for a year and was symptom free on no treatment at the time of reporting.3 A review of 15 cases of pulmonary lymphoproliferative conditions including three originally defined as "pseudolymphoma" showed monoclonality in 13 (including all three pseudolymphomas). Patients with diffuse or patchy lung shadowing on radiography had been treated with a mixture of chemotherapy regimens containing steroids, two receiving steroids and chlorambucil alone. One of these was lost to follow up and the other had a clinical response with no change in the radiographic appearance.4 Insufficient detail is given in this and other reports8 to evaluate the regimens used. Two of a reported series of 13 patients with lymphocytic interstitial pneumonitis were treated with chlorambucil and steroids with improvement in one.'0 There is no consensus established for the treatment of these conditions. As histologically these patients have low grade lymphoma, we chose to treat our two patients with steroids and chlorambucil, agents well tried and effective for other types of low grade B cell lymphoma and chronic lymphatic leukaemia and used successfully in some patients with "pseudolymphoma". To date this approach has produced a good response in these two patients.
